Operational excellence in the pharmaceutical industry:
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Aulendorf
ECV - Ed.-Cantor-Verl.
2006
|
| Schlagworte: | |
| Online-Zugang: | Inhaltstext Inhaltsverzeichnis |
| Beschreibung: | Literaturverz. S. 187 - 190 |
| Beschreibung: | 190 S. Ill., graph. Darst. |
| ISBN: | 3871933503 9783871933509 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV022253110 | ||
| 003 | DE-604 | ||
| 005 | 20201214 | ||
| 007 | t | ||
| 008 | 070201s2006 gw ad|| |||| 00||| eng d | ||
| 015 | |a 06,N13,0196 |2 dnb | ||
| 015 | |a 06,A25,1485 |2 dnb | ||
| 016 | 7 | |a 978783190 |2 DE-101 | |
| 020 | |a 3871933503 |c Pp. : EUR 90.00 |9 3-87193-350-3 | ||
| 020 | |a 9783871933509 |9 978-3-87193-350-9 | ||
| 024 | 3 | |a 9783871933509 | |
| 035 | |a (OCoLC)181550026 | ||
| 035 | |a (DE-599)BVBBV022253110 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 044 | |a gw |c XA-DE-BW | ||
| 049 | |a DE-1102 |a DE-19 | ||
| 084 | |a VB 4010 |0 (DE-625)147021:253 |2 rvk | ||
| 084 | |a 650 |2 sdnb | ||
| 245 | 1 | 0 | |a Operational excellence in the pharmaceutical industry |c ed. by Thomas Friedli ... With contributions from Bart Bastoen ... |
| 264 | 1 | |a Aulendorf |b ECV - Ed.-Cantor-Verl. |c 2006 | |
| 300 | |a 190 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 500 | |a Literaturverz. S. 187 - 190 | ||
| 650 | 4 | |a Industrial management | |
| 650 | 4 | |a Pharmaceutical industry |x Management | |
| 650 | 0 | 7 | |a Benchmarking |0 (DE-588)4329573-3 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Pharmazeutische Industrie |0 (DE-588)4045696-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Lean Management |0 (DE-588)4300840-9 |2 gnd |9 rswk-swf |
| 651 | 7 | |a Europa |0 (DE-588)4015701-5 |2 gnd |9 rswk-swf | |
| 655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
| 689 | 0 | 0 | |a Europa |0 (DE-588)4015701-5 |D g |
| 689 | 0 | 1 | |a Pharmazeutische Industrie |0 (DE-588)4045696-1 |D s |
| 689 | 0 | 2 | |a Benchmarking |0 (DE-588)4329573-3 |D s |
| 689 | 0 | 3 | |a Lean Management |0 (DE-588)4300840-9 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Friedli, Thomas |d 1971- |e Sonstige |0 (DE-588)122511107 |4 oth | |
| 700 | 1 | |a Bastoen, Bart |e Sonstige |4 oth | |
| 856 | 4 | 2 | |q text/html |u http://deposit.dnb.de/cgi-bin/dokserv?id=2782134&prov=M&dok_var=1&dok_ext=htm |3 Inhaltstext |
| 856 | 4 | 2 | |m GBV Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=015463876&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-015463876 | ||
Datensatz im Suchindex
| _version_ | 1804136250019414016 |
|---|---|
| adam_text | 2 ^ F J * 3 I: C 2. OPERATIONAL EXCELLENCE IN THE PHARMACEUTICAL
INDUSTRY EDITED BY THOMAS FRIEDLI, MICHAEL KICKUTH, FRANK STIENEKER,
PETER THALER, AND JIIRGEN WERANI WITH CONTRIBUTIONS FROM BART BASTOEN,
STEPHEN E. CHICK, THOMAS FRIEDLI, KEITH GOFFIN, DAVID HAMPTON, MICHAEL
KICKUTH, CHRISTOPH H. LOCH, HERMANN OSTERWALD, BRUCE RAMSAY, GERRIT
REEPMEYER, MAREK SZWEJCZEWSKI, DANIEL TYKAL, MALCOLM WHEATLEY, JURGEN
WERANI, AND BART DEWOLF EDITIO CANTOR VERLAG AULENDORF (GERMANY)
CONTENTS PREFACE EDITORS, AUTHORS, AND ACKNOWLEDGEMENTS INTRODUCTION
LIST OF ABBREVIATIONS 10 12 14 I CHALLENGES IN THE PHARMACEUTICAL
INDUSTRY GERRIT REEPMEYER AND MICHAEL KICKUTH 1.1 DECLINING RFTD
PRODUCTIVITY 1.2 CHANGING MARKET CONDITIONS 1.3 INCREASING COMPETITION
1.4 INCREASING COSTS AND LOW OPERATING EFFICIENCY 1.5 IMPLICATIONS FOR
MANUFACTURING 17 17 21 23 24 26 II A REFERENCE MODEL FOR OPERATIONAL
EXCELLENCE MICHAEL KICKUTH, THOMAS FRIEDLI, CHRISTOPH H. LOCH, AND
STEPHEN E. CHICK 11.1 II.2 II.3 INTRODUCTION MANAGEMENT QUALITY AND
FACTORY PERFORMANCE DEVELOPING THE OPERATIONAL EXCELLENCE REFERENCE
MODEL FOR THE OPEX PROJECT 30 30 32 40 CONTENTS III THE STATUS OF THE
PHARMACEUTICAL INDUSTRY 53 MICHAEL KICKUTH, THOMAS FRIEDLI, PETER
THALER, DANIEL TYKAL, AND HERMANN OSTERWALD 111.1 HOW DO PHARMACEUTICAL
COMPANIES RESPOND TO THE CHANGING ENVIRONMENT? 55 111.2 COST SAVINGS
POTENTIAL - WHAT IS THE MAIN LEVERAGE FOR STREAMLINING OPERATIONS? 56
111.3 LINKING PRACTICE TO PERFORMANCE: TESTING THE OPERATIONAL
EXCELLENCE MODEL 58 111.4 LINKING OPERATIONAL EXCELLENCE TO OVERALL
PLANT PERFORMANCE 68 111.5 DOES OPERATIONAL EXCELLENCE MATTER FROM A
CORPORATE PERSPECTIVE? 69 111.6 INSIGHTS FROM THE PLANT AUDITS 70 111.7
SPECIAL INSIGHTS FROM A CONTRACT MANUFACTURER - THE CASE OF NEXTPHARMA
77 IV OPERATIONAL EXCELLENCE IN THE PHARMACEUTICAL INDUSTRY: CASE
STUDIES FROM THE FIELD 82 MICHAEL KICKUTH, THOMAS FRIEDLI, DANIEL TYKAL,
MAREK SZWEJEZEWSKI, KEITH GOFFIN, MALCOLM WHEATLEY, BART BASTOEN, BART
DEWOLF, DAVID HAMPTON, CHRISTIAN EWERS, CHRISTOPH H. LOCH, STEPHEN
CHICK, AND BRUCE RAMSAY IV.1 CASE STUDY: LAUNCHING AN OPERATIONAL
EXCELLENCE INITIATIVE IN A GLOBAL PHARMACEUTICAL COMPANY - THE CASE OF
PFIZER INC. 82 IV.2 CASE STUDY: THE CAPSUGEL WAY TO OPERATIONAL
EXCELLENCE 95 IV.3 CASE STUDY: MAXIMIZING EQUIPMENT EFFECTIVENESS AT
RECKITT BENCKISER 102 IV.4 CASE STUDY: ACHIEVING 6-SIGMA LEVELS AT A
PHARMACEUTICAL PLANT 110 IV.5 LEAN COMPLIANCE: IMPLEMENTING JUST-IN-TIME
(JIT) IN A REGULATED ENVIRONMENT 124 IV.6 THE ROLE OF MANAGEMENT QUALITY
IN THE CONTEXT OF OPERATIONAL EXCELLENCE 131 IV.7 STAGES OF OPERATIONAL
EXCELLENCE 138 CONTENTS V THE PHARMACEUTICAL PLANT OF THE FUTURE 147
MICHAEL KICKUTH AND THOMAS FRIEDLI V.1 THE PHARMACEUTICAL INDUSTRY IN
2010 147 V.2 IMPLICATIONS FOR MANUFACTURING 150 V.3 HOW TO RESPOND? 153
V.4 THE PLANT OF THE FUTURE 164 APPENDICES 171 REFERENCES 187
|
| adam_txt |
2 ^ F "J * 3 I: C "2. OPERATIONAL EXCELLENCE IN THE PHARMACEUTICAL
INDUSTRY EDITED BY THOMAS FRIEDLI, MICHAEL KICKUTH, FRANK STIENEKER,
PETER THALER, AND JIIRGEN WERANI WITH CONTRIBUTIONS FROM BART BASTOEN,
STEPHEN E. CHICK, THOMAS FRIEDLI, KEITH GOFFIN, DAVID HAMPTON, MICHAEL
KICKUTH, CHRISTOPH H. LOCH, HERMANN OSTERWALD, BRUCE RAMSAY, GERRIT
REEPMEYER, MAREK SZWEJCZEWSKI, DANIEL TYKAL, MALCOLM WHEATLEY, JURGEN
WERANI, AND BART DEWOLF EDITIO CANTOR VERLAG AULENDORF (GERMANY)
CONTENTS PREFACE EDITORS, AUTHORS, AND ACKNOWLEDGEMENTS INTRODUCTION
LIST OF ABBREVIATIONS 10 12 14 I CHALLENGES IN THE PHARMACEUTICAL
INDUSTRY GERRIT REEPMEYER AND MICHAEL KICKUTH 1.1 DECLINING RFTD
PRODUCTIVITY 1.2 CHANGING MARKET CONDITIONS 1.3 INCREASING COMPETITION
1.4 INCREASING COSTS AND LOW OPERATING EFFICIENCY 1.5 IMPLICATIONS FOR
MANUFACTURING 17 17 21 23 24 26 II A REFERENCE MODEL FOR OPERATIONAL
EXCELLENCE MICHAEL KICKUTH, THOMAS FRIEDLI, CHRISTOPH H. LOCH, AND
STEPHEN E. CHICK 11.1 II.2 II.3 INTRODUCTION MANAGEMENT QUALITY AND
FACTORY PERFORMANCE DEVELOPING THE OPERATIONAL EXCELLENCE REFERENCE
MODEL FOR THE OPEX PROJECT 30 30 32 40 CONTENTS III THE STATUS OF THE
PHARMACEUTICAL INDUSTRY 53 MICHAEL KICKUTH, THOMAS FRIEDLI, PETER
THALER, DANIEL TYKAL, AND HERMANN OSTERWALD 111.1 HOW DO PHARMACEUTICAL
COMPANIES RESPOND TO THE CHANGING ENVIRONMENT? 55 111.2 COST SAVINGS
POTENTIAL - WHAT IS THE MAIN LEVERAGE FOR STREAMLINING OPERATIONS? 56
111.3 LINKING PRACTICE TO PERFORMANCE: TESTING THE OPERATIONAL
EXCELLENCE MODEL 58 111.4 LINKING OPERATIONAL EXCELLENCE TO OVERALL
PLANT PERFORMANCE 68 111.5 DOES OPERATIONAL EXCELLENCE MATTER FROM A
CORPORATE PERSPECTIVE? 69 111.6 INSIGHTS FROM THE PLANT AUDITS 70 111.7
SPECIAL INSIGHTS FROM A CONTRACT MANUFACTURER - THE CASE OF NEXTPHARMA
77 IV OPERATIONAL EXCELLENCE IN THE PHARMACEUTICAL INDUSTRY: CASE
STUDIES FROM THE FIELD 82 MICHAEL KICKUTH, THOMAS FRIEDLI, DANIEL TYKAL,
MAREK SZWEJEZEWSKI, KEITH GOFFIN, MALCOLM WHEATLEY, BART BASTOEN, BART
DEWOLF, DAVID HAMPTON, CHRISTIAN EWERS, CHRISTOPH H. LOCH, STEPHEN
CHICK, AND BRUCE RAMSAY IV.1 CASE STUDY: LAUNCHING AN OPERATIONAL
EXCELLENCE INITIATIVE IN A GLOBAL PHARMACEUTICAL COMPANY - THE CASE OF
PFIZER INC. 82 IV.2 CASE STUDY: THE CAPSUGEL WAY TO OPERATIONAL
EXCELLENCE 95 IV.3 CASE STUDY: MAXIMIZING EQUIPMENT EFFECTIVENESS AT
RECKITT BENCKISER 102 IV.4 CASE STUDY: ACHIEVING 6-SIGMA LEVELS AT A
PHARMACEUTICAL PLANT 110 IV.5 LEAN COMPLIANCE: IMPLEMENTING JUST-IN-TIME
(JIT) IN A REGULATED ENVIRONMENT 124 IV.6 THE ROLE OF MANAGEMENT QUALITY
IN THE CONTEXT OF OPERATIONAL EXCELLENCE 131 IV.7 STAGES OF OPERATIONAL
EXCELLENCE 138 CONTENTS V THE PHARMACEUTICAL PLANT OF THE FUTURE 147
MICHAEL KICKUTH AND THOMAS FRIEDLI V.1 THE PHARMACEUTICAL INDUSTRY IN
2010 147 V.2 IMPLICATIONS FOR MANUFACTURING 150 V.3 HOW TO RESPOND? 153
V.4 THE PLANT OF THE FUTURE 164 APPENDICES 171 REFERENCES 187 |
| any_adam_object | 1 |
| any_adam_object_boolean | 1 |
| author_GND | (DE-588)122511107 |
| building | Verbundindex |
| bvnumber | BV022253110 |
| classification_rvk | VB 4010 |
| ctrlnum | (OCoLC)181550026 (DE-599)BVBBV022253110 |
| discipline | Chemie / Pharmazie Wirtschaftswissenschaften |
| discipline_str_mv | Chemie / Pharmazie Wirtschaftswissenschaften |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02226nam a2200541 c 4500</leader><controlfield tag="001">BV022253110</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20201214 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">070201s2006 gw ad|| |||| 00||| eng d</controlfield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">06,N13,0196</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">06,A25,1485</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">978783190</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3871933503</subfield><subfield code="c">Pp. : EUR 90.00</subfield><subfield code="9">3-87193-350-3</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783871933509</subfield><subfield code="9">978-3-87193-350-9</subfield></datafield><datafield tag="024" ind1="3" ind2=" "><subfield code="a">9783871933509</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)181550026</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV022253110</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">XA-DE-BW</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-1102</subfield><subfield code="a">DE-19</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VB 4010</subfield><subfield code="0">(DE-625)147021:253</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">650</subfield><subfield code="2">sdnb</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Operational excellence in the pharmaceutical industry</subfield><subfield code="c">ed. by Thomas Friedli ... With contributions from Bart Bastoen ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Aulendorf</subfield><subfield code="b">ECV - Ed.-Cantor-Verl.</subfield><subfield code="c">2006</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">190 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Literaturverz. S. 187 - 190</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Industrial management</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical industry</subfield><subfield code="x">Management</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Benchmarking</subfield><subfield code="0">(DE-588)4329573-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmazeutische Industrie</subfield><subfield code="0">(DE-588)4045696-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Lean Management</subfield><subfield code="0">(DE-588)4300840-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">Europa</subfield><subfield code="0">(DE-588)4015701-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Europa</subfield><subfield code="0">(DE-588)4015701-5</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Pharmazeutische Industrie</subfield><subfield code="0">(DE-588)4045696-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Benchmarking</subfield><subfield code="0">(DE-588)4329573-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="3"><subfield code="a">Lean Management</subfield><subfield code="0">(DE-588)4300840-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Friedli, Thomas</subfield><subfield code="d">1971-</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)122511107</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bastoen, Bart</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="q">text/html</subfield><subfield code="u">http://deposit.dnb.de/cgi-bin/dokserv?id=2782134&prov=M&dok_var=1&dok_ext=htm</subfield><subfield code="3">Inhaltstext</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">GBV Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=015463876&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-015463876</subfield></datafield></record></collection> |
| genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content |
| genre_facet | Aufsatzsammlung |
| geographic | Europa (DE-588)4015701-5 gnd |
| geographic_facet | Europa |
| id | DE-604.BV022253110 |
| illustrated | Illustrated |
| index_date | 2024-07-02T16:40:10Z |
| indexdate | 2024-07-09T20:53:24Z |
| institution | BVB |
| isbn | 3871933503 9783871933509 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-015463876 |
| oclc_num | 181550026 |
| open_access_boolean | |
| owner | DE-1102 DE-19 DE-BY-UBM |
| owner_facet | DE-1102 DE-19 DE-BY-UBM |
| physical | 190 S. Ill., graph. Darst. |
| publishDate | 2006 |
| publishDateSearch | 2006 |
| publishDateSort | 2006 |
| publisher | ECV - Ed.-Cantor-Verl. |
| record_format | marc |
| spelling | Operational excellence in the pharmaceutical industry ed. by Thomas Friedli ... With contributions from Bart Bastoen ... Aulendorf ECV - Ed.-Cantor-Verl. 2006 190 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Literaturverz. S. 187 - 190 Industrial management Pharmaceutical industry Management Benchmarking (DE-588)4329573-3 gnd rswk-swf Pharmazeutische Industrie (DE-588)4045696-1 gnd rswk-swf Lean Management (DE-588)4300840-9 gnd rswk-swf Europa (DE-588)4015701-5 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content Europa (DE-588)4015701-5 g Pharmazeutische Industrie (DE-588)4045696-1 s Benchmarking (DE-588)4329573-3 s Lean Management (DE-588)4300840-9 s DE-604 Friedli, Thomas 1971- Sonstige (DE-588)122511107 oth Bastoen, Bart Sonstige oth text/html http://deposit.dnb.de/cgi-bin/dokserv?id=2782134&prov=M&dok_var=1&dok_ext=htm Inhaltstext GBV Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=015463876&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Operational excellence in the pharmaceutical industry Industrial management Pharmaceutical industry Management Benchmarking (DE-588)4329573-3 gnd Pharmazeutische Industrie (DE-588)4045696-1 gnd Lean Management (DE-588)4300840-9 gnd |
| subject_GND | (DE-588)4329573-3 (DE-588)4045696-1 (DE-588)4300840-9 (DE-588)4015701-5 (DE-588)4143413-4 |
| title | Operational excellence in the pharmaceutical industry |
| title_auth | Operational excellence in the pharmaceutical industry |
| title_exact_search | Operational excellence in the pharmaceutical industry |
| title_exact_search_txtP | Operational excellence in the pharmaceutical industry |
| title_full | Operational excellence in the pharmaceutical industry ed. by Thomas Friedli ... With contributions from Bart Bastoen ... |
| title_fullStr | Operational excellence in the pharmaceutical industry ed. by Thomas Friedli ... With contributions from Bart Bastoen ... |
| title_full_unstemmed | Operational excellence in the pharmaceutical industry ed. by Thomas Friedli ... With contributions from Bart Bastoen ... |
| title_short | Operational excellence in the pharmaceutical industry |
| title_sort | operational excellence in the pharmaceutical industry |
| topic | Industrial management Pharmaceutical industry Management Benchmarking (DE-588)4329573-3 gnd Pharmazeutische Industrie (DE-588)4045696-1 gnd Lean Management (DE-588)4300840-9 gnd |
| topic_facet | Industrial management Pharmaceutical industry Management Benchmarking Pharmazeutische Industrie Lean Management Europa Aufsatzsammlung |
| url | http://deposit.dnb.de/cgi-bin/dokserv?id=2782134&prov=M&dok_var=1&dok_ext=htm http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=015463876&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT friedlithomas operationalexcellenceinthepharmaceuticalindustry AT bastoenbart operationalexcellenceinthepharmaceuticalindustry |